Not all people with CLL need therapy. Even with all modern advances, the iwCLL still endorses watchful observation for clients with asymptomatic sickness.86 This recommendation is based on no less than two randomized trials evaluating observation to possibly chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (FCR). Pemain baru pasti akan https://juliec085wdk2.laowaiblog.com/profile